Preliminary Results of a Nearly Completed Phase 1-2 Trial Using Trimodality Therapy in Patients With Post Prostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer

被引：0
|
作者：
Kumar, P. [1 ]
Veldhuizen, P. [1 ]
Thompson, M. A. [1 ]
Shen, X. [2 ]
Coster, J. [2 ]
Pinski, J. [3 ]
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2622
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [1] Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial
    Kumar, P.
    Veldhuizen, P.
    Thompson, M.
    Shen, X.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S186 - S186
  • [2] Preliminary updated results of a phase I/II trial using trimodality therapy in patients with post-prostatectomy high risk pathologic (p) T2-3N0M0 prostate cancer
    Kumar, Parvesh
    Van Veldhuizen, Peter J.
    Thompson, Mark
    Shen, Xinglei
    Coster, James
    Pinskl, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Results of a phase I-II trial using tri-modality therapy in patients with post-prostatectomy high risk pathologic (p) T2-3N0M0 prostate cancer.
    Kumar, Parvesh
    Van Veldhuizen, Peter
    Thompson, Mark
    Shen, Xinglei
    Pinski, Jacek K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Preliminary Results of an On-Going Phase 1/2 Trial of Trimodality Therapy Using Hormonal Therapy, Radiation Therapy (RT), and Concurrent Docetaxel in Patients With High-Risk Pathologic T2-3-N0M0 Prostate Cancer
    Kumar, P.
    Veldhuizen, P.
    Thompson, M.
    Shen, X.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S389 - S390
  • [5] Recently Updated Preliminary Results of an On-Going Phase 1/2 Trial Using Trimodality Therapy in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3NOMO Prostate Cancer
    Kumar, P.
    Veldhuizen, P. V.
    Thompson, M.
    Shen, X.
    Coster, J.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S457 - S457
  • [6] 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer
    Schulman, CC
    Debruyne, FMJ
    Forster, G
    Selvaggi, FP
    Zlotta, AR
    Witjes, WPJ
    EUROPEAN UROLOGY, 2000, 38 (06) : 706 - 713
  • [7] Adjuvant Treatment is Superior to Salvage Therapy for Pathological T2-3N0M0 or T1-4N1M0/T4N0M0 Esophageal Cancer after Radical Surgery
    Ni, W.
    Yang, J.
    Xiao, Z.
    Wang, X.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    Lv, J.
    Wang, X.
    Hui, Z.
    Zhang, T.
    Bi, N.
    Deng, L.
    Wang, W.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E175 - E176
  • [8] Results of a European randomized study comparing radical prostatectomy and radical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3N0M0 prostatic carcinoma
    Witjes, WPJ
    Schulman, CC
    Debruyne, FMJ
    MOLECULAR UROLOGY, 1998, 2 (03) : 181 - 185
  • [9] Postoperative Radiation Therapy in Pathologic T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase 3, Randomized Controlled Study
    Deng, W.
    Yang, J.
    Xiao, Z.
    Wang, X.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    Lv, J.
    Zhang, T.
    Bi, N.
    Wang, W.
    Deng, L.
    Hui, Z.
    Wang, L.
    He, J.
    Gao, S.
    Xue, Q.
    Mao, Y.
    Sun, K.
    Liu, X.
    Fang, D.
    Li, J.
    Wang, D.
    Mou, J.
    Zhao, J.
    Li, Z.
    Lei, W.
    Wang, Y.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S190 - S191
  • [10] The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer
    Luo, Chuanxu
    Zhong, Xiaorong
    Fan, Yu
    Wang, Chengshi
    Wang, Yu
    Luo, Ting
    BREAST, 2021, 60 : 1 - 5
12345